113 related articles for article (PubMed ID: 1481841)
21. Pathogenic mechanisms in osteochondrodysplasias.
Stanescu V; Stanescu R; Maroteaux P
J Bone Joint Surg Am; 1984 Jul; 66(6):817-36. PubMed ID: 6376516
[TBL] [Abstract][Full Text] [Related]
22. Effect of relaxin on the phenotype of collagens synthesized by cultured rabbit chondrocytes.
Bonaventure J; de La Tour B; Tsagris L; Eddie LW; Tregear G; Corvol MT
Biochim Biophys Acta; 1988 Nov; 972(2):209-20. PubMed ID: 2461230
[TBL] [Abstract][Full Text] [Related]
23. Immortalized human adult articular chondrocytes maintain cartilage-specific phenotype and responses to interleukin-1beta.
Robbins JR; Thomas B; Tan L; Choy B; Arbiser JL; Berenbaum F; Goldring MB
Arthritis Rheum; 2000 Oct; 43(10):2189-201. PubMed ID: 11037878
[TBL] [Abstract][Full Text] [Related]
24. In situ expression of collagen and proteoglycan genes in notochord and during skeletal development and growth.
Sandell LJ
Microsc Res Tech; 1994 Aug; 28(6):470-82. PubMed ID: 7949393
[TBL] [Abstract][Full Text] [Related]
25. Etodolac preserves cartilage-specific phenotype in human chondrocytes: effects on type II collagen synthesis and associated mRNA levels.
Goldring MB; Sohbat E; Elwell JM; Chang JY
Eur J Rheumatol Inflamm; 1990; 10(1):10-21. PubMed ID: 2146129
[TBL] [Abstract][Full Text] [Related]
26. Incorporation of structurally defective type II collagen into cartilage matrix in kniest chondrodysplasia.
Fernandes RJ; Wilkin DJ; Weis MA; Wilcox WR; Cohn DH; Rimoin DL; Eyre DR
Arch Biochem Biophys; 1998 Jul; 355(2):282-90. PubMed ID: 9675039
[TBL] [Abstract][Full Text] [Related]
27. Non-collagenous protein screening in the human chondrodysplasias: link proteins, cartilage oligomeric matrix protein (COMP), and fibromodulin.
Stanescu V; Do TP; Chaminade F; Maroteaux P; Stanescu R
Am J Med Genet; 1994 May; 51(1):22-8. PubMed ID: 8030664
[TBL] [Abstract][Full Text] [Related]
28. Abnormal type I collagen metabolism by cultured fibroblasts in lethal perinatal osteogenesis imperfecta.
Bateman JF; Mascara T; Chan D; Cole WG
Biochem J; 1984 Jan; 217(1):103-15. PubMed ID: 6421277
[TBL] [Abstract][Full Text] [Related]
29. A radiographic, morphologic, biochemical and molecular analysis of a case of achondrogenesis type II resulting from substitution for a glycine residue (Gly691-->Arg) in the type II collagen trimer.
Mortier GR; Wilkin DJ; Wilcox WR; Rimoin DL; Lachman RS; Eyre DR; Cohn DH
Hum Mol Genet; 1995 Feb; 4(2):285-8. PubMed ID: 7757081
[TBL] [Abstract][Full Text] [Related]
30. Structurally abnormal type II collagen in a severe form of Kniest dysplasia caused by an exon 24 skipping mutation.
Weis MA; Wilkin DJ; Kim HJ; Wilcox WR; Lachman RS; Rimoin DL; Cohn DH; Eyre DR
J Biol Chem; 1998 Feb; 273(8):4761-8. PubMed ID: 9468540
[TBL] [Abstract][Full Text] [Related]
31. Achondrogenesis type II, abnormalities of extracellular matrix.
Horton WA; Machado MA; Chou JW; Campbell D
Pediatr Res; 1987 Sep; 22(3):324-9. PubMed ID: 3309860
[TBL] [Abstract][Full Text] [Related]
32. The pathology of cartilage in chondrodysplasias.
Hwang WS; Tock EP; Tan KL; Tan LK
J Pathol; 1979 Jan; 127(1):11-8. PubMed ID: 469631
[TBL] [Abstract][Full Text] [Related]
33. Defective collagen fibril formation and mineralization in osteogenesis imperfecta with congenital joint contractures (Bruck syndrome).
Brenner RE; Vetter U; Stöss H; Müller PK; Teller WM
Eur J Pediatr; 1993 Jun; 152(6):505-8. PubMed ID: 8335019
[TBL] [Abstract][Full Text] [Related]
34. Characterization of an arginine 789 to cysteine substitution in alpha 1 (II) collagen chains of a patient with spondyloepiphyseal dysplasia.
Chan D; Taylor TK; Cole WG
J Biol Chem; 1993 Jul; 268(20):15238-45. PubMed ID: 8325895
[TBL] [Abstract][Full Text] [Related]
35. A specific collagen type II gene (COL2A1) mutation presenting as spondyloperipheral dysplasia.
Zabel B; Hilbert K; Stöss H; Superti-Furga A; Spranger J; Winterpacht A
Am J Med Genet; 1996 May; 63(1):123-8. PubMed ID: 8723097
[TBL] [Abstract][Full Text] [Related]
36. Reduced amounts of cartilage collagen fibrils and growth plate anomalies in transgenic mice harboring a glycine-to-cysteine mutation in the mouse type II procollagen alpha 1-chain gene.
Garofalo S; Vuorio E; Metsaranta M; Rosati R; Toman D; Vaughan J; Lozano G; Mayne R; Ellard J; Horton W
Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9648-52. PubMed ID: 1946380
[TBL] [Abstract][Full Text] [Related]
37. Type II collagenopathies: are there additional family members?
Freisinger P; Bonaventure J; Stoess H; Pontz BF; Emmrich P; Nerlich A
Am J Med Genet; 1996 May; 63(1):137-43. PubMed ID: 8723099
[TBL] [Abstract][Full Text] [Related]
38. A COL2A1 mutation in achondrogenesis type II results in the replacement of type II collagen by type I and III collagens in cartilage.
Chan D; Cole WG; Chow CW; Mundlos S; Bateman JF
J Biol Chem; 1995 Jan; 270(4):1747-53. PubMed ID: 7829510
[TBL] [Abstract][Full Text] [Related]
39. Characterization of a type II collagen gene (COL2A1) mutation identified in cultured chondrocytes from human hypochondrogenesis.
Horton WA; Machado MA; Ellard J; Campbell D; Bartley J; Ramirez F; Vitale E; Lee B
Proc Natl Acad Sci U S A; 1992 May; 89(10):4583-7. PubMed ID: 1374906
[TBL] [Abstract][Full Text] [Related]
40. Chondrodysplasia in transgenic mice harboring a 15-amino acid deletion in the triple helical domain of pro alpha 1(II) collagen chain.
Metsäranta M; Garofalo S; Decker G; Rintala M; de Crombrugghe B; Vuorio E
J Cell Biol; 1992 Jul; 118(1):203-12. PubMed ID: 1618904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
